Skip to main content
MedPathMedPath Home
Clinical Trials/IRCT201306031030N14
IRCT201306031030N14
Completed
Phase 2

The effect of N-Acetylcystein on prevention of Acute Renal injury due to Cyclosporine Administration in patients undergoing bone marrow transplantation

Hematology Oncology and SCT Research Center0 sites60 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsCondition 1: AML. Condition 2: ALL. Condition 3: Acute Renal injury.Acute myeloblastic leukaemiaAcute lymphoblastic leukaemia

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Condition 1: AML. Condition 2: ALL. Condition 3: Acute Renal injury.
Sponsor
Hematology Oncology and SCT Research Center
Enrollment
60
Status
Completed
Last Updated
8 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Hematology Oncology and SCT Research Center

Eligibility Criteria

Inclusion Criteria

  • •1\- Patients with acute myeloid leukemia or acute lymphocytic leukemia
  • •2\- Full match Allogeneic Bone Marrow Transplantation
  • •3\- Age between 15\-60 year old
  • •4\- Treatment of Cyclosporin after transplantation
  • •Exclusion criteria:
  • •1\- Patient under 15 year old
  • •2\- Patient with diabetes, chronic kidney disease, liver disorder or hypertension

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Effect of N - Acetylcysteine in the prevention of ototoxicity caused by vancomycin.Peritonitis.Peritonitis, unspecified
IRCT201202148032N2Research Assistance Of Tabriz University Of Medical Science60
Completed
Phase 2
Effect of N-acetylcysteine on preventation of postcardiac surgery atrial fibrillatio
IRCT201008134561N1Cardiac Research Center of Tabriz Universityof Medical sciences240
Recruiting
Phase 3
Prophylactic effect of N-acetyl-cysteine plus Atorvastatin versus N-acetyl-cysteine and Atorvastatin alone for the prevention of contrast induced nephropathyContrast induced nephropathy.Other complications following infusion, transfusion and therapeutic injectionT80.8
IRCT20180417039347N1Zahedan University of Medical Sciences250
Completed
Not Applicable
use of acetyl cystein in prevention of anti-TB drug induced hepatitisdrug induced hepatits.Toxic liver disease with hepatic necrosis
IRCT201205259855N1Arak University of Medical sciences
Completed
Phase 2
The effect of N-acetyl cysteine in preventing mucositis in patients undergoing bone marrow transplantatioCondition 1: Mucositis (oral). Condition 2: AML. Condition 3: ALL. Condition 4: MDS.Oral mucositis (ulcerative)Acute myeloblastic leukaemiaAcute lymphoblastic leukaemiaMyelodysplastic syndromes
IRCT201303301030N13Hematology Oncology and SCT Research Center64